Sharon Bio-Medicine Ltd. reported earnings results for the fourth quarter ended March 31, 2022. For the fourth quarter, the company reported revenue was INR 508.98 million compared to INR 506.48 million a year ago. Net income was INR 46.81 million compared to INR 56.1 million a year ago. Basic earnings per share from continuing operations was INR 8.13 compared to INR 9.75 a year ago.